Abivax: JP Morgan Chase below 5% of capital
(CercleFinance.com) - JP Morgan Chase & Co.
has declared to the AMF that, on March 4, 2025, it indirectly crossed below the threshold of 5% of the share capital of Abivax, and that it holds, indirectly through J.P. Morgan Securities plc and J.P. Morgan Securities plc, a subsidiary of Abivax. Morgan Securities plc and J.P. Morgan Securities LLC which it controls, 4.73% of the capital and 4.22% of the voting rights of this company.
This threshold crossing results from a reduction in the number of Abivax shares held by assimilation.
Copyright (c) 2025 CercleFinance.com. All rights reserved.